Introduction: Where We Stand in 2025

It has been more than five years since the COVID-19 pandemic began. It has disrupted our lives, economies, and health. From 2020 through 2021, we saw health care systems become overwhelmed, lockdowns, and just loss of life. Now that we are in 2025 and life is largely back to normal, many are trying to figure out if COVID is still a threat to us. The answer to that question is complicated. 

COVID-19 has evolved from a global pandemic to being endemic (similar to the flu). While there are new variants of COVID-19 that continue to emerge globally, the threat now is less significant because of vaccines, treatment options, and evolving patterns of natural immunity and spread. However, COVID-19 is still a legitimate risk, especially for high-risk populations, and with the emergence of new variants of the virus, there remains, to a small extent, continued uncertainty of the overall threat.

This blog aims to provide a perspective on the reality of COVID-19 in 2025. We’ll cover the most recent science, public health recommendations, new variants, vaccination-related information, and lots more.

COVID-19 in 2025: The Current Landscape

From Pandemic to Endemic: What Does It Mean?

Following the World Health Organization’s (WHO) official termination of COVID-19’s designation as a global health emergency in mid-2023, COVID-19 now can be treated like other ongoing health challenges, but is no longer subject to the emergency crisis management framework. COVID has not disappeared, but “normalizes” and is now part of a predictable daily routine, like influenza or the common cold.

In layman’s terms, endemic means the virus is always there; while it does not disappear, however, it is predictable. There are still seasonal spikes of COVID, but COVID will be easier to manage as the total number of hospitalizations and deaths decreases due to population-level immunity and therapeutics. Governments and health systems will no longer focus on end-to-end emergency management, but rather will shift back to managing outbreaks and some degree of ‘business-as-usual’ approaches.

That said, just because it is endemic does not mean it is benign; COVID still causes serious illness leading to death in internally displaced and vulnerable populations, and long COVID is a public health consideration for everyone.

Latest Variants: What We’re Dealing With Now

One important factor contributing to COVID’s threat is the mutations it has faced, creating new variants. In 2025, there are several variants out there, each with their own specific characteristics.

1. OmicronPi .2

The current dominant strain of COVID-19 globally is Omicron Pi.2. Pi.2 is a much more transmissible variant than the previous variants, even in communities with high vaccination rates. In vaccinated individuals, the majority are only experiencing mild to moderate symptoms: sore throat, fatigue, and congestion; thus, for most individuals, Pi.2 can be considered “just a cold.” However, because Pi.2 has been shown to evade immunity (from past infection or vaccines), it is still possible for vaccinated individuals (also known as breakthrough cases) to become infected by Pi.2 through partial immunity. More broadly, it is possible for individuals to be affected due to partial immunity. 

2. Sigma-X

Sigma-X is the newest variant, which is being observed in Europe and Southeast Asia, though gaining traction particularly in the colder months. The variant propagates easily. It includes resistance to certain monoclonal antibody treatments, which complicates treating vulnerable populations, particularly the elderly. In general, Sigma-X does not appear to cause severe illness in the majority of healthy individuals, although the expedited transmission continues to strain healthcare systems during seasonal spikes in hospitalizations.

3. HV.1 (Hybrid Variant)

HV.1 is a hybrid variant that consists of mutations from both the Delta and Omicron variants, which makes it a public health concern. At this time, HV.1 is not prevalent. However, it has started to show early signs of causing more severe respiratory symptoms, mainly in the lungs. This is a sign of a potential return to more severe forms of illness in some patients, and because of this potential, world health authorities will be monitoring this variant closely. The potential for higher severity of HV.1 makes it a variant to monitor, especially in places with low immunity and/or stressed health systems.

These variants highlight that COVID is dynamic and new variants can cause public health concerns. This is why it is important to continue to be updated and vaccinated.

Is COVID Still Dangerous in 2025?

General Public vs. High-Risk Populations

For most healthy people, especially fully vaccinated, COVID-19 in 2025 is more often only a mild illness (fever, cough, fatigue, sore throat). But for others, the danger has not passed.

High-risk groups include older adults over 65, as well as those with underlying health conditions, including cancer, diabetes, heart disease, and pregnant individuals or organ transplant recipients who have weakened immune systems. 

For these individuals, COVID-19 infections can still lead to severe pneumonia requiring hospitalization, multi-organ failure, or even death in the most severe cases. Additionally, some initially experiencing only mild symptoms may go on to develop long COVID, a debilitating post-viral condition now affecting millions worldwide in the years following the pandemic.

Long COVID: Life After Infection

Also known as Post-Acute Sequelae of SARS-CoV-2 infection or PASC, long COVID refers to an array of symptoms persisting for many weeks or even several months after the initial bout of illness. Research shows that between 5 to 10 percent of individuals contracting COVID in later years may experience prolonged symptoms.

1. Extreme Fatigue

Fatigue, in particular, remains the predominant long-lasting complaint, described as an overwhelming, deep-seated tiredness unimproved by rest or sleep. Unlike common fatigue, this pervasive type of exhaustion frequently hinders daily activities to such an extent that work, focus, and even basic self-care like getting out of bed become impossible. It is thought to be linked to the body’s ongoing and potentially dysregulated immune response as well as the struggle to return to pre-disease energy levels months after falling ill.

2. Brain Fog and Memory Issues

The term “brain fog” is a recognized conclusion, and its outcomes include difficulties with focus, memory, or reasoning. People may claim they feel sluggish mentally, are not able to finish or perform necessary daily activities, or experience distraction during conversations. These cognitive symptoms of brain fog can contribute to frustration and ramifications in daily life and work. These symptoms may last for weeks to months after a viral respiratory disease. Researchers are not quite clear about the causative mechanisms, other than they speculate these incapacitating cognitive symptoms could potentially be due to inflammation or a change in cerebral blood flow, since these issues follow infection.

3. Breathlessness

Dyspnea, or shortness of breath, can be present even after the resolution of the acute illness related to a respiratory infection. Dyspnea can occur due to ineffective breathing, deterioration in lung function, or prolonged lung inflammation. Dyspnea may be distressing and lead to limited activity temporarily until the dyspnea recovers; this could be due to the experience of shortness of breath at even low levels of exertion, such as walking or climbing stairs.

4. Chest Pain

Many people develop chronic chest pain, pressure, or tightness long after their initial illness. It may be a result of inflammation of the wall of the chest cavity or irritation of the heart or lungs. Anxiety related to long COVID could also be related. In general, chest pain, discomfort, and pressure is not life threatening but can be disconcerting, not to mention concerning if it worsens or is associated with other symptoms such as dizziness or palpitations.

5. Anxiety and Depression

The emotional toll of chronic symptoms, loneliness with cessation of daily routine or social gratification, and uncertainty for recovery can contribute to increased anxiety and depression. Some people may experience panic attacks, mood shifts, or feelings of hopelessness. In addition, the virus may have direct effects on brain chemistry, which could be contributory to anxiety and depression even in people without a previous diagnosis of anxiety or depression. 

In some cases, people never return to work or their behaviors or activities for months, which may have a long-term health, insurance, or employment impact. 

The landscape surrounding treatments and support systems has progressed, but there is still no treatment for long COVID, leaving vaccination and hygiene as the best defence against long COVID.

Vaccination in 2025: Where We Stand

By 2025, the COVID-19 vaccines will be in process. The next generation of COVID-19 vaccines has improved for the changing nature of COVID variants, including Pi 2. In addition, the new mRNA vaccines are better at preventing COVID infection and serious disease. Another feature has been added so that future generations of COVID-19 vaccines will target more variants simultaneously, like flu vaccines have.

Another benefit is that these updated vaccines are faster to develop and have fewer side effects, making them ultimately easier and more acceptable to the general public. These COVID-19 vaccines are available in many locations such as clinics, pharmacies, airports, and even workplaces. It is much easier than in the past to get the vaccine. Immunizations are:

1. More effective

The new generation of COVID-19 vaccines in 2025 has been designed with specific variants in mind for dominant variation, such as Pi 2. These new vaccinations are more effective at limiting the infection and spread of COVID and the risks of severe disease. These developed vaccines give increased protection beyond the previous variants available, and instead target variants with immune escape properties, which gives people greater and more reliable immunity.

2. Rapid production

Thanks to the developments in mRNA technology and the global coordination of vaccine efforts, we are better equipped to be responsive to the pandemic. After additional variants emerge, new updated vaccines can be designed and produced in weeks, allowing public health systems to stay ahead of outbreaks while allowing us to be protected.

3. Better tolerated, with fewer side effects

The current vaccines, which are on the market, have been further optimized to decrease the side effects of the products (fever, fatigue, and soreness). There have been enough clinical trials and post-market safety surveillance that these manufacturers can make recommendations for formulation and dosing that will have a better outcome and are better tolerated by our bodies. These products are likely more easily tolerated than previously by all populations (even sensitive populations).

4. Available anywhere

Vaccines are available at nearly every hospital, clinic, pharmacy, airport, and workplace. This wide engagement allows easy access, increases the likelihood of vaccines being accepted by populations, and makes staying protected as easy as possible for people by requiring very little change to their daily lives.

Vaccines are available literally anywhere, from pharmacies, mobile units, workplaces, and airports allowing the easy access necessary for getting people vaccinated.

Health Expert Commentary in 2025

Dr. Leena Patel, an infectious disease specialist, states:

“COVID is no longer a global crisis, but it is not something we can put our heads in the sand about. COVID is like the flu—annoying, sometimes dangerous, and still something we should protect ourselves against”. 

The WHO is also clear that vigilance is still warranted:

“We are entering a period that is characterized by co-existing with COVID-19. With science, vaccines, and smart behaviours, we will be able to reduce its impact and protect the most vulnerable.”

Conclusion

Yes, COVID-19 is still a threat, but a threat that we know and understand. COVID-19 exists in our society with updated vaccines, more intelligent strategies in public health, and community understanding than we had in 2020.

The virus continues to mutate, and it’s still capable of harming you. By making good choices such as getting your booster shot, wearing a mask when appropriate, and practicing good hygiene, you can help protect yourself and others from COVID-19.

COVID may be here for the long haul, but so is our ability to fight back.